1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAcademic Innovation Zone is sponsored by Pennsylvania Biotechnology Center (PABC). A pilot program to accelerate and support life sciences startups in Pennsylvania, providing financial support and free lab space at PABC facilities in Doylestown, Philadelphia (B+labs), and elsewhere in Pennsylvania.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pennsylvania Biotechnology Center to support promising life sciences startups through its new Academic Innovation Zone program – Baruch S.
Blumberg Institute Pennsylvania Biotechnology Center to support promising life sciences startups through its new Academic Innovation Zone program Pennsylvania Biotechnology Center to support promising life sciences startups through its new Academic Innovation Zone program Doylestown Website Design Through a pilot program aimed at accelerating and supporting life sciences startups in our state, the Pennsylvania Biotechnology Center (PABC) will provide financial support and free lab space to more than a dozen startups at the PABC in Doylestown, its B+labsincubator in Philadelphia and elsewhere in Pennsylvania.
The PABC’s new initiative, the Academic Innovation Zone, is managing $5 million through the Commonwealth of Pennsylvania from the federal Coronavirus State Fiscal Recovery Funds. Ranked as one of the nation’s most successful life sciences incubators, the PABC operates two facilities. Headquartered in Doylestown, the PABC operates B+labs at Cira Centre , a two-year-old facility in University City, Philadelphia.
There are nearly 70 companies at the two locations, and both are filled to capacity with a waiting list of other life sciences companies interested in locating at a PABC facility. The goal of the Academic Innovation Zone is to support early stage life science companies and academic technologies, while attracting companies to Pennsylvania and creating more high-quality jobs.
Over the last year, this initiative has helped companies relocate to Pennsylvania from New York City, Delaware, Utah and Toronto. Three companies already at the PABC in Doylestown: Aprea Therapeutics Inc., Evrys Bio LLC and Incite Health, are using the funds to expand their footprints as they prepare for clinical trials.
The 11 companies that have received PABC Academic Innovation Zone support since the first allocations were made last September are: Aprea Therapeutics, Doylestown, Eliska Therapeutics, Doylestown, Incite Health, Doylestown, Merlin Biotech, Inc., Doylestown, Nucleate Regional Hub, Philadelphia, Synergy Therapeutics, Doylestown, Nous Biosciences, Doylestown, Virion Therapeutics, Philadelphia, and Young Therapeutics, Doylestown.
Additionally, significant funds have been allocated for new company creation at B+labs in Philadelphia. “This is a pilot fund to help recruit academic technologies and newly formed companies to Pennsylvania, and to retain the best biotech inventions that emerge from our universities,” Louis P. Kassa III, MPA, president and CEO of the PABC, said.
“Our goal is to propel, accelerate and support early stage biotech companies by providing funding, services and lab space. ” The PABC has a strategic partnership with the Wistar Institute and companies at PABC incubators are commercializing technologies from the University of Pennsylvania, Childrens Hospital of Philadelphia, Princeton University, the University of Utah and other institutions.
The Academic Innovation Zone program has engaged two talent scouts, who are highly experienced biotech experts, to find companies for both incubators as well as other locations in Pennsylvania. A committee composed of biotech scientists and professionals in venture capital, business development and commercial real estate selected the 10 companies for funding and free lab space in this first round.
Expanding the program statewide is one of the AIZ team’s goals, according to Kassa. They have been talking with legislators and Gov. Shapiro’s administration about funding for that purpose. Located in Doylestown, Pa.
, in the heart of the Philadelphia-New Jersey pharma belt, the Pennsylvania Biotechnology Center (PABC) is a nonprofit life sciences incubator-accelerator offering state-of-the-art laboratory and office space to nearly 50 early-stage biotech companies.
The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. To date, more than 75 companies have called PABC their home.
PABC tenants account for 17% of all National Institutes of Health SBIR grants awarded in Pennsylvania and over the years have created billions of dollars in market value from IPOs, acquisitions and commercial valuations. For more information, please visit the PABC website .
According to the current listing, eligibility includes: Early-stage life science companies and academic technologies, including those relocating to Pennsylvania. Confirm the full requirements in the official notice before applying.
Academic Innovation Zone is funded by Pennsylvania Biotechnology Center (PABC). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Pennsylvania. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Commonwealth Financing Authority's statewide Local Share Account program accepts applications September 1 through November 30, 2026, funding public-interest projects from $25,000 in eligible costs up to $1,000,000 per grant request out of Pennsylvania gaming revenue. Nonprofits are not eligible applicants and must be sponsored by a county, municipality, authority, or development agency. Here is how the sponsorship structure actually works, what the three-month window is really for, and why the ownership-and-maintenance clause decides more applications than the project narrative.
Read articleThe Hewlett Foundation's Emerging Technology and Security Initiative commits $20 million a year through 2031 across AI, biotechnology, and quantum computing security. Its 2026 exploratory grants went to thirteen named institutions with no open call. For organizations outside that list, the path in runs through a specific set of moves — and the five-year term starting in 2027 is the window.
Read articleThe Energy Department's first Genesis Mission SBIR/STTR Phase I solicitation offers roughly 40 awards of up to $250,000 against $10 million — but you cannot submit a full application anymore. A four-question, 700-word pitch now decides who gets to apply, there is no Direct to Phase II path for new entrants, and the $147.4 million Phase II pool is closed to everyone who has never won a DOE award.
Read article